Anchyra Partners
AVXL icon

Anchyra Partners’s Anavex Life Sciences AVXL Stock Holding History

Anchyra Partners’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$28.9K Buy
+14,294
New +$39.5K 0.01% 422

Other funds holding AVXL

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Apella Capital
Apella Capital West Hartford, Connecticut $7.88B AUM 10.78% 1-Year Est. Return
PVG Asset Management
PVG Asset Management Golden, Colorado $147M AUM 52.72% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Hikari Power
Hikari Power Tokyo, Japan $439M AUM 11.38% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Anchyra Partners's AVXL Position: Q3 2026 in Review

Anchyra Partners opened a new position in Anavex Life Sciences (AVXL) in Q3 2026: 14,294 shares worth $28.9K. The stake represents 0.01% of the portfolio and ranks #422 among its holdings.

74 funds tracked by Wall St. Rank hold AVXL as of Q3 2026.

  • Anchyra Partners held 14,294 shares of Anavex Life Sciences worth $28.9K as of Q3 2026.
  • Anavex Life Sciences was a new Anchyra Partners position in Q3 2026.
  • Anavex Life Sciences made up 0.01% of Anchyra Partners's portfolio in Q3 2026, its #422 holding.
  • 74 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q3 2026.

Based on Anchyra Partners's 13F filing for Q3 2026, filed 13 Oct 2026.